ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Prevention Facility For Intramural Research Approved, Also Would Involve Academic Investigators

November 1, 1991

In brief: Shalala Meets HIV-Infected Children; Einstein’s Kornblith Moves To PCI; Yang Leaves Center

March 12, 1993

ACS To Implement Cancer Response Systems Nationwide

August 2, 1985

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

House Passes 2.8 Percent Increase For NCI

December 11, 2009

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014